Maxime Boussageon

Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients

Jean‐Philippe Foy, Andy Karabajakian, Sandra Ortiz‐Cuaran et al. · European Journal of Cancer · 2022 · 66 citations

Life Sciences, Immunology, Oncology +17

Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer

Sandra Ortiz‐Cuaran, Aurélie Swalduz, Jean‐Philippe Foy et al. · European Journal of Cancer · 2022 · 32 citations

Medicine, Immunology, Oncology +14

Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitors

Jean‐Philippe Foy, Andy Karabajakian, Sandra Ortiz‐Cuaran et al. · Data in Brief · 2022 · 20 citations · Full text

Medicine, Molecular Biology, Oncology +17

Occupational asbestos exposure and survival among lung cancer patients

H. Noelle, Olivia Pérol, M. Pérol et al. · Lung Cancer · 2023 · 16 citations · Full text

Medicine, Health Sciences, Oncology +14